- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2014
- Public Summary Document (PSD) November 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2014 PBAC Meeting - Word
Elosulfase alfa – November 2014
Elosulfase alfa; 1 mg/mL concentrate for solution for infusion, 5mL vial; Vimizim®
Last updated
20 March 2015